Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial

María Diez‐Campelo, Félix López Cadenas, Blanca Xicoy, Eva Lumbreras, Teresa González, Mónica Del Rey González, Joaquín Sánchez‐García, Rosa Coll Jordà, Bohrane Slama, José‐Ángel Hernández‐Rivas, Sylvain Thépot, Teresa Bernal, Agnès Guerci‐Bresler, Joan Bargay, María Luz Amigo, Claude Preudhomme, Laurène Fenwarth, Uwe Platzbecker, Katharina S. Götze, Ali Arar, Sofía Toribio, Consuelo del Cañizo, Jesús María Hernández‐Rivas, Pierre Fenaux